Detalhe da pesquisa
1.
Impact of different exposure models and spatial resolution on the long-term effects of air pollution.
Environ Res
; 192: 110351, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33130163
2.
KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study.
Haematologica
; 105(6): 1604-1612, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31537689
3.
Immunoglobulin kappa deleting element rearrangements are candidate targets for minimal residual disease evaluation in mantle cell lymphoma.
Hematol Oncol
; 38(5): 698-704, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32816326
4.
Minimal residual disease (MRD) in non-Hodgkin lymphomas: Interlaboratory reproducibility on marrow samples with very low levels of disease within the FIL (Fondazione Italiana Linfomi) MRD Network.
Hematol Oncol
; 37(4): 368-374, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31325190
5.
HashClone: a new tool to quantify the minimal residual disease in B-cell lymphoma from deep sequencing data.
BMC Bioinformatics
; 18(1): 516, 2017 Nov 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-29169317
6.
Comparison of two real-time quantitative polymerase chain reaction strategies for minimal residual disease evaluation in lymphoproliferative disorders: correlation between immunoglobulin gene mutation load and real-time quantitative polymerase chain reaction performance.
Hematol Oncol
; 32(3): 133-8, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24254547
7.
Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: evidences from long term follow-up.
Br J Haematol
; 181(5): 693-695, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28369711
8.
Rituximab-based pre-emptive treatment of molecular relapse in follicular and mantle cell lymphoma.
Ann Hematol
; 92(11): 1503-11, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23737092
9.
A Clinical Prognostic Model Based on Machine Learning from the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III Trial.
Cancers (Basel)
; 14(1)2021 Dec 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35008361
10.
Applying Data Warehousing to a Phase III Clinical Trial From the Fondazione Italiana Linfomi Ensures Superior Data Quality and Improved Assessment of Clinical Outcomes.
JCO Clin Cancer Inform
; 3: 1-15, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31633999
11.
Rituximab, bendamustine, and low-dose cytarabine as induction therapy in elderly patients with mantle cell lymphoma: a multicentre, phase 2 trial from Fondazione Italiana Linfomi.
Lancet Haematol
; 4(1): e15-e23, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27927586
12.
Minimal Residual Disease Detection by Droplet Digital PCR in Multiple Myeloma, Mantle Cell Lymphoma, and Follicular Lymphoma: A Comparison with Real-Time PCR.
J Mol Diagn
; 17(6): 652-60, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26319783
13.
Clinical implications and prognostic role of minimal residual disease detection in follicular lymphoma.
Ther Adv Hematol
; 4(3): 189-98, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23730496
14.
Telomere loss in Philadelphia-negative hematopoiesis after successful treatment of chronic myeloid leukemia: evidence for premature aging of the myeloid compartment.
Mech Ageing Dev
; 133(7): 479-88, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22687638
15.
IGF-I induces caveolin 1 tyrosine phosphorylation and translocation in the lipid rafts.
Biochem Biophys Res Commun
; 295(5): 1085-9, 2002 Aug 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-12135605